# THRIVE Feasibility Trial

> **NCT05346588** · PHASE3 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 300 (actual)

## Conditions studied

- Surgery--Complications
- Anesthesia Complication
- Anesthesia Awareness
- Anesthesia Emergence Delirium
- Anesthesia
- Surgery
- Quality of Life
- Pain, Postoperative
- Nausea, Postoperative
- Anesthesia Morbidity
- Depression
- Sleep Disorders, Circadian Rhythm

## Interventions

- **OTHER:** Anesthetic technique Propofol TIVA
- **OTHER:** Anesthetic technique inhaled agent

## Key facts

- **NCT ID:** NCT05346588
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-29
- **Primary completion:** 2023-04-16
- **Final completion:** 2023-06-28
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2023-11-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05346588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05346588, "THRIVE Feasibility Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05346588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*